- Home /
- Live Rates /
- RGC

RGC
Last Updated: Jun 17, 2026 03:07:58 PM (GMT)
RGC: The current market price is 15.99, with a percentage change of -5.1% from the previous price.
Support and Resistance Levels Current support levels are at 16.85, while resistance levels are also at 16.85, making the pivot point 16.85.
Indicators The RSI is at 36.28, indicating bearish momentum, while the ATR is 0.14376, suggesting low volatility. The MACD is at -0.12782, with a bearish signal. The Parabolic SAR is at 17.80844, continuing in bearish alignment. The 50-day SMA is 17.56971, and the 200-day EMA is at 18.78985, indicating a bearish trend.
Market Sentiment The current price is below the pivot point of 16.85, suggesting a bearish scenario supported by RSI, MACD, and other indicators.
RGC Signals & Technical Analysis
Market Sentiment
Trend Indicators
Oscillators
Moving Averages
Pivot
About (RGC) Regencell Bioscience Holdings Limited
Company Background
Regencell Bioscience Holdings Limited, symbol RGC (NASDAQ:RGC), is a biotechnology company headquartered in Hong Kong, focused on developing traditional Chinese medicine (TCM)-based therapies for neurocognitive and neurodegenerative disorders. Founded in 2014, the company aims to bridge the gap between ancient medical wisdom and modern scientific research by creating natural, holistic treatment solutions for conditions such as Attention Deficit Hyperactivity Disorder (ADHD) and Autism Spectrum Disorder (ASD). Regencell’s mission is to improve patient quality of life through innovative, safe, and effective treatments that integrate traditional herbal formulations with rigorous scientific validation and modern manufacturing standards.
Market Position
Regencell Bioscience holds a niche position in the global biotechnology and alternative medicine sectors by combining traditional Chinese medicine with modern biopharmaceutical research. The company differentiates itself through its proprietary herbal formulations and its focus on neurological and mental health disorders—areas that remain underserved by conventional medicine. Regencell is among the few publicly listed biotechnology companies emphasizing natural, evidence-based therapeutics derived from TCM principles. Its strategic R&D approach leverages partnerships with research institutions and clinicians to conduct clinical studies and validate the safety and efficacy of its treatments. The company’s commitment to scientific transparency and patient-centered outcomes strengthens its credibility in the growing field of integrative medicine.
Key Financial and Industry Highlights
Regencell Bioscience remains in the early stages of commercial development but demonstrates strong growth potential as global demand for alternative and holistic healthcare solutions continues to rise. The company’s long-term strategy centers on expanding its clinical pipeline, securing regulatory approvals, and scaling production to meet international standards. Its emphasis on natural, non-invasive therapies aligns with global health trends favoring wellness and preventive medicine. Regencell’s solid financial foundation—supported by disciplined capital management and strategic partnerships—enables continued investment in clinical research and product development.
As the convergence of traditional and modern medicine gains momentum, Regencell Bioscience is well-positioned to lead innovation in natural therapeutics for neurological and behavioral disorders. With its unique scientific approach, commitment to quality, and focus on addressing unmet medical needs, Regencell Bioscience Holdings Limited represents a forward-looking model in the evolution of biotechnology and holistic healthcare.
How to Buy or Trade Regencell Bioscience Holdings Ltd. Stock (RGC) with AvaTrade
Trading or investing in Regencell Bioscience Holdings Ltd. stock through AvaTrade starts with opening a verified trading account. After registration, complete the KYC verification process by submitting your ID and proof of address, then fund your account using a supported payment method such as bank transfer, debit card, or e-wallet. Once your funds reflect, log into the AvaTrade platform or mobile app and search for the ticker symbol RGC, which represents Regencell Bioscience Holdings Ltd.. Before placing a trade, review the live Regencell Bioscience Holdings Ltd. share price, market trend, spread, leverage options, and recent market news that could impact the stock price.
The next step is deciding whether you want to buy or sell Regencell Bioscience Holdings Ltd. stock. Traders expecting the price to rise typically open a Buy position, while traders expecting weakness in the sector may open a Sell position using CFDs. Enter your preferred trade size, then apply risk management tools such as a stop-loss to limit downside exposure and a take-profit order to secure profits automatically. After confirming the trade, monitor key drivers including Regencell Bioscience Holdings Ltd. earnings reports, product or service announcements, business segment performance, revenue growth, and overall stock market sentiment. Many traders also use technical indicators such as moving averages, RSI, and support/resistance levels available on the AvaTrade platform to improve timing and trading decisions.
Related Stocks
Indicator Alert
Warning: Several indicator values are missing for this timeframe. Please choose another timeframe to continue.
Sidebar rates
- <% signal.pair %>
<% signal.analyst %>
